Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001671617-16-000001
Filing Date
2016-04-08
Accepted
2016-04-08 17:34:05
Documents
1
Period of Report
2016-02-16

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 2667
  Complete submission text file 0001671617-16-000001.txt   4143
Mailing Address 37 NORTH ORANGE AVENUE SUITE 607 ORLANDO FL 32801
Business Address 37 NORTH ORANGE AVENUE SUITE 607 ORLANDO FL 32801 (888) 613-8802
Immune Therapeutics, Inc. (Issuer) CIK: 0001559356 (see all company filings)

EIN.: 593226705 | State of Incorp.: FL | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3990 OLD TOWN AVE STE A112 SAN DIEGO CA 92110
Business Address
Selsky Clifford (Reporting) CIK: 0001671617 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-54933 | Film No.: 161563532